久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

江蘇正大天晴藥業(yè)股份有限公司是集科研、生產(chǎn)和銷(xiāo)售為一體的大型醫(yī)藥企業(yè)，是國(guó)內(nèi)最大的肝健康藥物研發(fā)和生產(chǎn)基地之一。江蘇正大天晴藥業(yè)是國(guó)家重點(diǎn)高新技術(shù)企業(yè)、國(guó)家火炬計(jì)劃連云港新醫(yī)藥產(chǎn)業(yè)基地重點(diǎn)骨干企業(yè)、中國(guó)制藥工業(yè)百?gòu)?qiáng)企業(yè)。

江蘇正大天晴藥業(yè)產(chǎn)品治療涉及肝病、腫瘤、糖尿病、呼吸、心腦血管、抗感染、消化、神經(jīng)等多個(gè)疾病領(lǐng)域，特別是在肝病藥物研究領(lǐng)域具備獨(dú)特的優(yōu)勢(shì)。主要產(chǎn)品有潤(rùn)眾（恩替卡韋分散片）、名正（阿德福韋酯膠囊）、甘利欣（甘草酸二銨注射液及其膠囊）、天晴甘美（異甘草酸鎂注射液）、天晴復(fù)欣（苦參素葡萄糖注射液）、天晴甘平（甘草酸二銨腸溶膠囊）、天晴依泰（唑來(lái)膦酸注射液）等。“天晴甘美”、“天晴甘平”、“名正”先后獲得中國(guó)國(guó)際專(zhuān)利博覽會(huì)金獎(jiǎng)，“天晴甘美”獲得具有中國(guó)專(zhuān)利奧斯卡之稱(chēng)的“中國(guó)專(zhuān)利金獎(jiǎng)”。

正大天晴藥物研究院分為南京研發(fā)中心和連云港研發(fā)中心，擁有國(guó)家級(jí)博士后科研工作站、江蘇省新型肝病藥物工程技術(shù)研究中心兩個(gè)掛牌單位，中國(guó)工程院院士、著名肝病專(zhuān)家莊輝先生擔(dān)任江蘇省新型肝病藥物工程技術(shù)研究中心專(zhuān)家委員會(huì)主任。正大天晴藥物研究院的建立，使正大天晴已具備國(guó)內(nèi)先進(jìn)水平的研發(fā)創(chuàng)新平臺(tái)。未來(lái)的正大天晴藥物研究院將形成1院5所的結(jié)構(gòu)，包括已經(jīng)建成的南京開(kāi)發(fā)所，連云港優(yōu)化所，和將要建立的上海創(chuàng)新所、北京創(chuàng)新所和美國(guó)信息所。

隨著正大天晴創(chuàng)新能力的不斷加強(qiáng)，自主創(chuàng)新成果碩果累累，企業(yè)的核心競(jìng)爭(zhēng)力不斷提升。目前正大天晴在甘草制劑領(lǐng)域的研究已取得國(guó)內(nèi)第一、世界領(lǐng)先地位，成為國(guó)內(nèi)在此領(lǐng)域研究歷史最長(zhǎng)、獲得成果最多的企業(yè)。“十五”以來(lái)，公司先后承擔(dān)了40多項(xiàng)國(guó)家、省級(jí)重大科技項(xiàng)目，其中“863”計(jì)劃3項(xiàng)，“十一五”“重大新藥創(chuàng)制”科技重大專(zhuān)項(xiàng)3項(xiàng)，省科技成果轉(zhuǎn)化專(zhuān)項(xiàng)資金項(xiàng)目3項(xiàng)，培育國(guó)家重點(diǎn)新產(chǎn)品6個(gè)，江蘇省高新技術(shù)產(chǎn)品15個(gè)。江蘇正大天晴藥業(yè)目前擁有5家全資子公司和4家控股子公司，在連云港建有三個(gè)生產(chǎn)基地，總占地面積800余畝。其中：位于連云港市區(qū)東側(cè)的廠區(qū)，占地140畝，分別建有大、小容量注射劑、固體制劑、中藥提取、粉針劑等生產(chǎn)車(chē)間；位于連云港經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)大浦工業(yè)園區(qū)的原料藥基地——潤(rùn)眾制藥，占地200多畝，主導(dǎo)產(chǎn)品為恩替卡韋、異甘草酸鎂、甘草酸二銨、阿德福韋酯、羥乙基淀粉等20余個(gè)品種的原料藥和中間體；位于連云港海州經(jīng)濟(jì)開(kāi)發(fā)區(qū)的海州制劑新區(qū)規(guī)劃面積480畝，總投資10億元，車(chē)間均按照歐盟和美國(guó)FDA標(biāo)準(zhǔn)設(shè)計(jì)建設(shè)，部分產(chǎn)品將出口歐美等主流藥品市場(chǎng)。公司始終堅(jiān)持走質(zhì)量效益發(fā)展之路，將質(zhì)量管理作為企業(yè)生產(chǎn)管理的重中之重，堅(jiān)持“把產(chǎn)品質(zhì)量視為企業(yè)的生命之本，把客戶(hù)滿意作為企業(yè)的不懈追求”的質(zhì)量方針，公司分別于2000年、2004年、2007年度獲得“江蘇省質(zhì)量管理獎(jiǎng)”。為了保證藥品質(zhì)量，正大天晴藥業(yè)在國(guó)家法定標(biāo)準(zhǔn)基礎(chǔ)上，建立了一套遠(yuǎn)高于國(guó)家法定標(biāo)準(zhǔn)的企業(yè)內(nèi)控標(biāo)準(zhǔn)，還致力于采用國(guó)際標(biāo)準(zhǔn)和國(guó)外先進(jìn)標(biāo)準(zhǔn)。

未來(lái)的江蘇正大天晴藥業(yè)將繼續(xù)秉承創(chuàng)新理念，以“健康人類(lèi)，共創(chuàng)美好未來(lái)”為宗旨，致力于藥物創(chuàng)新，努力開(kāi)拓國(guó)際市場(chǎng)，把公司建立成為“以專(zhuān)利藥為龍頭的產(chǎn)品鏈和產(chǎn)品結(jié)構(gòu)，以研發(fā)為驅(qū)動(dòng)力、營(yíng)銷(xiāo)為中心，集生產(chǎn)制造于一體的現(xiàn)代制藥企業(yè)”。
 

Brief introduction for Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd.

Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. is a large pharmaceutical manufacturer which integrates research, production and sales as a whole. It is also one of the largest researching and manufacturing bases and state key high and new technology enterprises, major enterprises of Lianyungang new medical industrial base of state torch plan, and one of the top 100 powers of China pharmaceutical industry.

Jiangsu Chia-tai Tianqing Pharmaceutical Company’s products involves in hepatitis, cancer, cardio-vascular, anti-virus, digestion, respiratory, diabetes etc., particularly possesses advantages in hepatopathy fields. Its products like runzhong, adefovir, ganlixin, ganmei, tianqing yitai, ganping, mingzheng won golden award of China International Patent Right Fair. Tianqing ganmei won China patent golden award, which is honorably named Chinese Oscar reputation.

The research institute has Lianyungang and Nanjing branches with two boards that postal doctoral program and Jiangsu engineering technology research center for new type hepatopathy medicine hanged on. Mr. Zhuang Hui, a outstanding scientist who also is academician of China Academy, assumes the office of director of Experts Commission for Jiangsu Engineering Technology Research Center for New Type Hepatopathy Medicines. The building of CTTQ’s institute equips itself a platform of domestic advanced innovation and research. CTTQ’s medicines research institute will be composed by Nanjing and Lianyungang branches which already put in practical work, and Shanghai Renovation Branch, Beijing Developing Branch, and American Information Branch.

The company’s core competitive ability is strengthened as it’s renovation ability level is upgraded and fruitful achievements achieved. Now CTTQ’s licorice extracts research is leading both at home and abroad not only for the longest history but also the most fruitful achievements. Since the period of 10th-five years plan, the company assumed 40 state and province major science and technology items, including 3 items of 863 plan, 3 items of important new medicine renovation of 11th-five years plan, 3 items of provincial science and technology application and transfer special programs. It explores 6 state key new products and 15 new high technology products.

CTTQ has 5 complete capitalized-controlled sub-companies, 4 majority capitalized-controlled sub-companies and 3 manufacture bases with a covering area of 55 hectares. Located in the east area of Lianyungang, the general plan with large volume and small volume injection, solid prescription products, traditional Chinese herbal extract workshops, covers an area of 140 mu. Located in Lianyungang economic and technology developing zone, Rain join pharmacy, covering an area of 200 mu, is a bulk drug manufacture plant mainly dealing with more than 20 sorts of inter-media and raw materials such as aderfovir, enticuvir, licorice extracts, starch. With a total one billion CNY investment and an area of 200 mu, Haechow new prescription plant’s workshops was designed and constructed according with E.U. and FDA regulation. Some of its products will be sold afar in the oversea market like the U.S. and Europe.

The company always insists on the balance between quality and profits. It focuses great attention on quality control management which among enterprise management. The company keeps the principles that quality is the grass root of enterprise’s life and keeps seeking to satisfy the clients. It won the reward of Jiangsu quality management in 2000, 2004, and 2007. To insure the medicines’ quality, the company set up a new enterprise homely-controlled standard priority to state legal standard which it based on. It also devotes to international standard and advanced foreign standard.

Chia-tai Tianqing Pharmacy sets up Lianyungang chia-tai tianqing medical co., Ltd., which is specialized in professional academic promotion and sales for medicines in market. Leading by latest sales concepts, the sales company emphasizes greatly the academic promotion for medicines. Leading by market sales, and the company builds up modern medical sales system with a strong professional academic team.

Aiming at the principle of promoting people’s health, creating a paradise future, Jiangsu Chia-tai Tianqing Pharmacy will inherit the concept of innovation, devotes to medicine’s innovation and exploring international market, Being driven by patented medicines and sales , Chia-Tai Tianqing pharmacy will soon grow into a modern pharmaceutical manufacturer which integrates manufacture and research as a whole.